Exploring Advances in IL-17 Treatments and Their Efficacy

This chapter discusses the latest advancements in IL-17 inhibitors, focusing on treatments like bimikizumab and secukinumab. It highlights significant improvements in inflammation for patients with enthesitis, supported by real-world data demonstrating decreased inflammatory markers post-therapy.